''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation

Table 1 Clinical characteristics of 235 consecutive liver transplant patients

Variables		Value
Age (yr)		47.11 ± 11.32
MELD score		16 (range 6-50)
Child score		9 (range 5-15)
Gender	Male	203 (86.4)
	Female	32 (13.6)
Etiology	HBV-related	140 (59.6)
	Hepatocarcinoma	55 (23.4)
	Others	40 (17)
Blood tests	Bilirubin (μmol/L) (NR < 17.1)	162.73 ± 205.39
	AST (IU/L) (NR < 50)	240.46 ± 556.16
	ALT (IU/L) (NR < 40)	183.2 ± 325.93
	Albumin (g/L) (NR 35-50)	34.96 ± 5.47
	WBC (× 109/L) (NR 3.5-11)	5.96 ± 4.58
	Urea (mmol/L) (NR 3-7.1)	6.70 ± 5.29
	Creatinine (μmol/L) (NR 60-97)	94.37 ± 68.98
TC		7.91 ± 2.28
ABO	A-A	85 (36.2)
	B-B	51 (21.7)
	O-O	87 (37)
	AB-AB	12 (5.1)

Data are expressed as absolute numbers (percentage) or mean ± SD. NR: Normal range; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; WBC: White blood cell; HBV: Hepatitis B virus.